Crystal structure of carbonmonoxy sickle hemoglobin in R-state conformationMohini S. Ghatge, Martin K. Safo, Mostafa H. Ahmed et al.|Journal of Structural Biology|2016Cited by 35
VZHE-039, a novel antisickling agent that prevents erythrocyte sickling under both hypoxic and anoxic conditionsOsheiza Abdulmalik, Martin K. Safo, Piyusha P. Pagare et al.|Scientific Reports|2020Cited by 25
Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual propertyPiyusha P. Pagare, Martin K. Safo, Aref Rastegar et al.|Expert Opinion on Therapeutic Patents|2021Cited by 22
Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agentsAbdelsattar M. Omar, Martin K. Safo, Mona A. Mahran et al.|Organic & Biomolecular Chemistry|2015Cited by 22
Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Prodrugs as Drug Candidates for the Treatment of Ischemic Disorders: Insights into NO-Releasing Prodrug Biotransformation and Hemoglobin–NO BiochemistryGuoyan Xu, Martin K. Safo, Mohini S. Ghatge et al.|Biochemistry|2015Cited by 12